In addition, baicalin reduced inflammatory responses to reduce lung cancer by acting on SOCS1/NF-κB/STAT3 axis [28], ameliorated Mycoplasma gallisepticum-elicited inflammatory damage by diminishing ceramide accumulation in DF-1 cells [29] and alleviated lung inflammatory responses and fibrosis elicited by silica through diminishing TLR4/NF-kB pathway in rats [30]. Here, NFKB1 is linked to lung cancer.